Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions.
暂无分享,去创建一个
T. Mohr | E. Hovig | J. De las Rivas | A. Scorilas | A. Tolios | P. Trouillas | A. Tolios | J. De Las Rivas | E. Hovig | P. Trouillas | A. Scorilas | T. Mohr | J. de Las Rivas | J De Las Rivas
[1] S. Stigler. Gauss and the Invention of Least Squares , 1981 .
[2] E. Diamandis,et al. Cancer biomarkers: can we turn recent failures into success? , 2010, Journal of the National Cancer Institute.
[3] S. Aller,et al. Allosteric Role of Substrate Occupancy Toward the Alignment of P-glycoprotein Nucleotide Binding Domains , 2018, Scientific Reports.
[4] Robert Clarke,et al. Differential dependency network analysis to identify condition-specific topological changes in biological networks , 2009, Bioinform..
[5] M. Care,et al. Parsimonious Gene Correlation Network Analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer , 2019, npj Systems Biology and Applications.
[6] Genwei Zhang,et al. Towards rapid prediction of drug-resistant cancer cell phenotypes: single cell mass spectrometry combined with machine learning. , 2019, Chemical communications.
[7] Yingzi Wang,et al. Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma , 2019, BMC Cancer.
[8] Y. Zhang,et al. IntAct—open source resource for molecular interaction data , 2006, Nucleic Acids Res..
[9] M. Gottesman,et al. Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.
[10] Ricardo J. Ferreira,et al. Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein , 2013, J. Chem. Inf. Model..
[11] Robert Tibshirani,et al. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.
[12] Shashank Kumar,et al. Emerging targets in cancer drug resistance , 2019, Cancer drug resistance.
[13] Y. Assaraf,et al. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[14] Hassane S. Mchaourab,et al. On the Origin of Large Flexibility of P-glycoprotein in the Inward-facing State* , 2013, The Journal of Biological Chemistry.
[15] R. Fisher. THE USE OF MULTIPLE MEASUREMENTS IN TAXONOMIC PROBLEMS , 1936 .
[16] Eric P. Xing,et al. Network Analysis of Breast Cancer Progression and Reversal Using a Tree-Evolving Network Algorithm , 2014, PLoS Comput. Biol..
[17] Max Kuhn,et al. caret: Classification and Regression Training , 2015 .
[18] Sarah A Heerboth,et al. Drug Resistance in Cancer: An Overview , 2014, Cancers.
[19] Tianyang Sun,et al. Drug promiscuity of P-glycoprotein and its mechanism of interaction with paclitaxel and doxorubicin. , 2014, Soft matter.
[20] A. Scorilas,et al. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease , 2018, Clinical chemistry and laboratory medicine.
[21] S. Horvath,et al. A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.
[22] Yidong Chen,et al. scdNet: a computational tool for single-cell differential network analysis , 2018, BMC Systems Biology.
[23] G. Yousef,et al. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes , 2015, Tumor Biology.
[24] K. Berka,et al. Structural patterns of the human ABCC4/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms , 2018, Pharmacological Research.
[25] T. Mohr,et al. Proteome profiling in IL-1β and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis , 2017, PloS one.
[26] S. Horvath. Weighted Network Analysis: Applications in Genomics and Systems Biology , 2011 .
[27] Sung Young Kim,et al. Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method , 2018, Cancer research and treatment : official journal of Korean Cancer Association.
[28] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[29] Lin Song,et al. Comparison of co-expression measures: mutual information, correlation, and model based indices , 2012, BMC Bioinformatics.
[30] E. Lindahl,et al. Membrane proteins: molecular dynamics simulations. , 2008, Current opinion in structural biology.
[31] Thalia E. Chan,et al. Gene Regulatory Network Inference from Single-Cell Data Using Multivariate Information Measures , 2016, bioRxiv.
[32] Eivind Hovig,et al. Predicting Physical Interactions between Protein Complexes* , 2013, Molecular & Cellular Proteomics.
[33] Marcus W Beck,et al. NeuralNetTools: Visualization and Analysis Tools for Neural Networks. , 2018, Journal of statistical software.
[34] L. Scott. Larotrectinib: First Global Approval , 2019, Drugs.
[35] F. Meric-Bernstam,et al. Challenges with biomarkers in cancer drug discovery and development , 2018, Expert opinion on drug discovery.
[36] Hui Zhang,et al. A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method , 2011, Comput. Biol. Medicine.
[37] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[38] Xinyi Liu,et al. Deep-Resp-Forest: A deep forest model to predict anti-cancer drug response. , 2019, Methods.
[39] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[40] Giovanni Iacono,et al. Single-Cell Transcriptomics Unveils Gene Regulatory Network Plasticity , 2018 .
[41] Y. Assaraf,et al. Modulating ROS to overcome multidrug resistance in cancer. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[42] Ruo-Pan Huang,et al. Cytokines in cancer drug resistance: Cues to new therapeutic strategies. , 2016, Biochimica et biophysica acta.
[43] Tingting Fu,et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics , 2017, Nucleic Acids Res..
[44] Funda Meric-Bernstam,et al. Building a personalized medicine infrastructure at a major cancer center. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] Ingebrigt Sylte,et al. Theoretical Biology and Medical Modelling Open Access Binding Site of Abc Transporter Homology Models Confirmed by Abcb1 Crystal Structure , 2022 .
[46] Ashutosh Singh,et al. Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer , 2018, Scientific Reports.
[47] Henning Hermjakob,et al. The Reactome pathway Knowledgebase , 2015, Nucleic acids research.
[48] A. Scorilas,et al. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer. , 2019, Carcinogenesis.
[49] Luis Rueda. Microarray Image and Data Analysis : Theory and Practice , 2018 .
[50] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[51] Qing Zhao,et al. Deciphering the associations between gene expression and copy number alteration using a sparse double Laplacian shrinkage approach , 2015, Bioinform..
[52] Arvind K. Bansal,et al. In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies , 2013, Journal of Computer-Aided Molecular Design.
[53] Lili Liu,et al. Selective reversal of BCRP‐mediated MDR by VEGFR‐2 inhibitor ZM323881 , 2017, Biochemical pharmacology.
[54] Carlos Prieto,et al. APID: Agile Protein Interaction DataAnalyzer , 2006, Nucleic Acids Res..
[55] Septimiu E. Salcudean,et al. Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images , 2019, JAMA network open.
[56] Deng Pan,et al. DGIdb 2.0: mining clinically relevant drug–gene interactions , 2015, Nucleic Acids Res..
[57] A. Scorilas,et al. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. , 2015, International journal of oncology.
[58] L Zhang,et al. Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium , 2013, Clinical pharmacology and therapeutics.
[59] J. Kowal,et al. Structural insight into substrate and inhibitor discrimination by human P-glycoprotein , 2019, Science.
[60] J. Lee,et al. Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells , 2019, Communications Biology.
[61] Min Zhang,et al. Systematic identification of non-coding pharmacogenomic landscape in cancer , 2018, Nature Communications.
[62] Duhee Bang,et al. Multiplexed single-cell RNA-seq via transient barcoding for simultaneous expression profiling of various drug perturbations , 2019, Science Advances.
[63] K. Ogawa,et al. Mechanisms of Resistance to Kinase Inhibitors and Strategies to Prevent the Development of Drug Resistance , 2018 .
[64] I. Amit,et al. Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq , 2016, Cell.
[65] Gerhard F. Ecker,et al. Prediction of drug–ABC-transporter interaction — Recent advances and future challenges☆ , 2015, Advanced drug delivery reviews.
[66] Maria P. Pavlou,et al. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer , 2010, Nature Reviews Cancer.
[67] O. Firuzi,et al. Molecular dynamics simulation and molecular docking studies of 1,4-Dihydropyridines as P-glycoprotein’s allosteric inhibitors , 2018, Journal of biomolecular structure & dynamics.
[68] Luciana Gavernet,et al. Docking Applied to the Prediction of the Affinity of Compounds to P-Glycoprotein , 2014, BioMed research international.
[69] Yufei Huang,et al. Predicting drug response of tumors from integrated genomic profiles by deep neural networks , 2018, BMC Medical Genomics.
[70] Jie Tang,et al. Environmental Research and Public Health Long Non-coding Rna as Potential Biomarker for Prostate Cancer: Is It Making a Difference? , 2022 .
[71] Ricardo J. Ferreira,et al. Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies , 2017, Scientific Reports.
[72] E. Nice,et al. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification , 2017, Expert review of proteomics.
[73] F. Zunino,et al. Overview of tumor cell chemoresistance mechanisms. , 2005, Methods in molecular medicine.
[74] L. Monticelli,et al. Calculating the free energy of transfer of small solutes into a model lipid membrane: Comparison between metadynamics and umbrella sampling. , 2015, The Journal of chemical physics.
[75] Othman Soufan,et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis , 2019, Nucleic Acids Res..
[76] Zhe-Sheng Chen,et al. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. , 2018, Cancer letters.
[77] E. Pardon,et al. Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain , 2013, Proceedings of the National Academy of Sciences.
[78] Yehuda G Assaraf,et al. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[79] K. Kuchler,et al. The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion , 2017, Scientific Reports.
[80] E. Krieger,et al. Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity. , 2012, Biochemical pharmacology.
[81] Ziv Bar-Joseph,et al. Network-guided prediction of aromatase inhibitor response in breast cancer , 2019, PLoS Comput. Biol..
[82] C. Etchebest,et al. New insights into GluT1 mechanics during glucose transfer , 2019, Scientific Reports.
[83] J. Stanton. Galton, Pearson, and the Peas: A Brief History of Linear Regression for Statistics Instructors , 2001 .
[84] Su-In Lee,et al. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia , 2018, Nature Communications.
[85] J. F. Wang,et al. Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach , 2004, J. Chem. Inf. Model..
[86] I. Gould,et al. Modeling the Effect of BSEP Inhibitors in Lipid Bilayers by Means of All-Atom Molecular Dynamics Simulation , 2019, ACS Omega.
[87] Gerhard F Ecker,et al. Predicting drug resistance related to ABC transporters using unsupervised Consensus Self-Organizing Maps , 2018, Scientific Reports.
[88] E. Giovannetti,et al. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[89] Chris Wiggins,et al. ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.
[90] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[91] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[92] K. Berka,et al. Behavior of human cytochromes P450 on lipid membranes. , 2013, The journal of physical chemistry. B.
[93] Justin Guinney,et al. Systematic Assessment of Analytical Methods for Drug Sensitivity Prediction from Cancer Cell Line Data , 2013, Pacific Symposium on Biocomputing.
[94] Y. Assaraf,et al. Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance , 2011, PloS one.
[95] Diego Alonso-López,et al. Human Interactomics: Comparative Analysis of Different Protein Interaction Resources and Construction of a Cancer Protein-Drug Bipartite Network. , 2018, Advances in protein chemistry and structural biology.
[96] Y. Assaraf,et al. Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[97] Y. Assaraf,et al. Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance. , 2005, Cancer research.
[98] Julia M. Barbarino,et al. PharmGKB: A worldwide resource for pharmacogenomic information , 2018, Wiley interdisciplinary reviews. Systems biology and medicine.
[99] E. Hovig,et al. Differential Protein Network Analysis of the Immune Cell Lineage , 2014, BioMed research international.
[100] Carlos Prieto,et al. APID interactomes: providing proteome-based interactomes with controlled quality for multiple species and derived networks , 2016, Nucleic Acids Res..
[101] Ting Gong,et al. DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data , 2013, Bioinform..
[102] J. S. Cramer. The Origins of Logistic Regression , 2002 .
[103] K. Schulten,et al. Permeability of a Fluid Lipid Bilayer to Short-Chain Alcohols from First Principles. , 2017, Journal of chemical theory and computation.
[104] T. Oguri,et al. Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort , 2019, BMC Cancer.
[105] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[106] Katherina Baranova,et al. Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning , 2016, Molecular oncology.
[107] Xander A A M Verbeek,et al. Transformation of the National Breast Cancer Guideline Into Data-Driven Clinical Decision Trees. , 2019, JCO clinical cancer informatics.
[108] L. O’Driscoll,et al. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance , 1997, International journal of cancer.
[109] Johannes Zuber,et al. Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence , 2017, Genes & development.
[110] Yunming Ye,et al. Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneity , 2018, Nature Communications.
[111] Mahmoud Moradi,et al. Mechanistic picture for conformational transition of a membrane transporter at atomic resolution , 2013, Proceedings of the National Academy of Sciences.
[112] R. Nitsch,et al. CRISPR-UMI: single-cell lineage tracing of pooled CRISPR–Cas9 screens , 2017, Nature Methods.
[113] Leo Breiman,et al. Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001 .
[114] Nandhitha Subramanian,et al. Probing the Pharmacological Binding Sites of P-Glycoprotein Using Umbrella Sampling Simulations , 2018, J. Chem. Inf. Model..
[115] Per Artursson,et al. Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.
[116] Hisanori Kiryu,et al. SCODE: an efficient regulatory network inference algorithm from single-cell RNA-Seq during differentiation , 2016, bioRxiv.
[117] Y. Assaraf,et al. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[118] V. Koshkin,et al. Single-cell-kinetics approach to compare multidrug resistance-associated membrane transport in subpopulations of cells. , 2011, Analytical chemistry.
[119] Ricardo J. Ferreira,et al. Reversing cancer multidrug resistance: insights into the efflux by ABC transports from in silico studies , 2015 .
[120] M. Zloh,et al. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein , 2014, SAR and QSAR in environmental research.
[121] M. O'Kane,et al. Practical guide for identifying unmet clinical needs for biomarkers , 2018, EJIFCC.
[122] Arieh Warshel,et al. ZnT2 is an electroneutral proton-coupled vesicular antiporter displaying an apparent stoichiometry of two protons per zinc ion , 2019, PLoS Comput. Biol..
[123] A. Ravna,et al. Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4). , 2008, Bioorganic & medicinal chemistry letters.
[124] Jing Wang,et al. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit , 2017, Nucleic Acids Res..
[125] Thomas M. Norman,et al. Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens , 2016, Cell.
[126] Viktor Hornak,et al. Structure-Kinetic Relationships of Passive Membrane Permeation from Multiscale Modeling. , 2017, Journal of the American Chemical Society.
[127] Sung Young Kim,et al. Machine learning identifies a core gene set predictive of acquired resistance to EGFR tyrosine kinase inhibitor , 2018, Journal of Cancer Research and Clinical Oncology.
[128] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[129] Yiyu Cheng,et al. Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm , 2007, J. Chem. Inf. Model..
[130] Y. Assaraf,et al. Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers , 2012, Cell Death and Disease.
[131] Riccardo Zecchina,et al. A Prize-Collecting Steiner Tree Approach for Transduction Network Inference , 2009, CMSB.
[132] Michael Hecker,et al. Gene regulatory network inference: Data integration in dynamic models - A review , 2009, Biosyst..
[133] Fabian J Theis,et al. Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals hidden subpopulations of cells , 2015, Nature Biotechnology.
[134] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[135] Daniel F Hayes,et al. Cancer biomarkers , 2012, Molecular oncology.
[136] P. Souček,et al. ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[137] A. Schlessinger,et al. Molecular Modeling of Drug–Transporter Interactions—An International Transporter Consortium Perspective , 2018, Clinical pharmacology and therapeutics.
[138] E. Giovannetti,et al. Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[139] P. Biggin,et al. Towards understanding promiscuity in multidrug efflux pumps. , 2014, Trends in biochemical sciences.
[140] Joanna L. Sharman,et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..
[141] Nancy R. Zhang,et al. Bulk tissue cell type deconvolution with multi-subject single-cell expression reference , 2018, Nature Communications.
[142] Rosalinde Masereeuw,et al. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. , 2008, Trends in pharmacological sciences.
[143] Somnath Datta,et al. Integrating gene regulatory pathways into differential network analysis of gene expression data , 2019, Scientific Reports.
[144] A. Scorilas,et al. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers , 2018, Expert review of molecular diagnostics.
[145] Brian D. Ripley,et al. Modern Applied Statistics with S Fourth edition , 2002 .
[146] Kurt Hornik,et al. Multilayer feedforward networks are universal approximators , 1989, Neural Networks.
[147] Karthik Raman,et al. The organisational structure of protein networks: revisiting the centrality–lethality hypothesis , 2013, Systems and Synthetic Biology.
[148] Jue Chen,et al. Crystal structure of the multidrug transporter P-glycoprotein from C. elegans , 2012, Nature.
[149] Q. Cui,et al. A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations , 2010, PloS one.
[150] Y. Assaraf,et al. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[151] A. di Pietro,et al. Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2′-deoxyuridine-5′-monophosphate on ABCC11 in silico models , 2013, BMC Structural Biology.
[152] T. Jenssen,et al. A literature network of human genes for high-throughput analysis of gene expression , 2001, Nature Genetics.
[153] G. Várady,et al. Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression , 2018, Scientific Reports.
[154] G. Coukos,et al. Personalized approaches to active immunotherapy in cancer. , 2016, Biochimica et biophysica acta.
[155] Robert O'Connor,et al. Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents , 2007, Expert opinion on drug metabolism & toxicology.
[156] S. Sardari,et al. Informatics of drug synergism in naturally occurring anticancer agents. , 2011, Recent patents on anti-cancer drug discovery.
[157] S. W. Lee,et al. Acral melanoma detection using a convolutional neural network for dermoscopy images , 2018, PloS one.
[158] Jianping Zhou,et al. Mechanisms of TPGS and its derivatives inhibiting P-glycoprotein efflux pump and application for reversing multidrug resistance in hepatocellular carcinoma , 2018 .
[159] Pedro J. Ballester,et al. Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours , 2017, Oncotarget.
[160] G. Yousef,et al. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[161] Carlton Anthony Taft and Carlos Henrique Tomich de Paula d Silva. Cancer and Aids: New Trends in Drug Design and Chemotherapy , 2006 .
[162] Jianing Song,et al. Insights on Na+ binding and conformational dynamics in multidrug and toxic compound extrusion transporter NorM , 2014, Proteins.
[163] Nicholas J Provart,et al. Analyses of Protein Interaction Networks Using Computational Tools. , 2018, Methods in molecular biology.
[164] A. Tiwari,et al. Cariprazine, A Dopamine D2/D3 Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer , 2018, Cancers.
[165] R. Kim,et al. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics. , 2018, Cold Spring Harbor perspectives in medicine.
[166] D. M. Vera,et al. Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study. , 2013, Journal of molecular graphics & modelling.
[167] Won-Ho Shin,et al. Deep learning of mutation-gene-drug relations from the literature , 2017, BMC Bioinformatics.
[168] Jean-Pierre Gillet,et al. Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.
[169] A. Barabasi,et al. Lethality and centrality in protein networks , 2001, Nature.
[170] M Michael Gromiha,et al. Drug-Target Interactions: Prediction Methods and Applications. , 2018, Current protein & peptide science.
[171] D. Tieleman,et al. Coarse-grained molecular dynamics simulations reveal lipid access pathways in P-glycoprotein , 2018, The Journal of general physiology.
[172] A. C. Gasparovic,et al. What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[173] Barbara Zdrazil,et al. Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning , 2016, Journal of Cheminformatics.
[174] S. Horvath,et al. Protein expression based multimarker analysis of breast cancer samples , 2011, BMC Cancer.
[175] Arieh Warshel,et al. Demonstrating aspects of multiscale modeling by studying the permeation pathway of the human ZnT2 zinc transporter , 2018, PLoS Comput. Biol..
[176] André F. Rendeiro,et al. Pooled CRISPR screening with single-cell transcriptome read-out , 2017, Nature Methods.
[177] Bernd Bischl,et al. mlr: Machine Learning in R , 2016, J. Mach. Learn. Res..
[178] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[179] Jihye Kim,et al. DSigDB: drug signatures database for gene set analysis , 2015, Bioinform..
[180] A. Fernández-Medarde,et al. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[181] Thomas Girke,et al. systemPipeR: NGS workflow and report generation environment , 2016, BMC Bioinformatics.
[182] Y. Assaraf,et al. Lysosomes as mediators of drug resistance in cancer. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[183] A. Mai,et al. Epigenetic polypharmacology: A new frontier for epi‐drug discovery , 2020, Medicinal research reviews.
[184] Georg Heinze,et al. Variable selection – A review and recommendations for the practicing statistician , 2018, Biometrical journal. Biometrische Zeitschrift.
[185] Davis J. McCarthy,et al. f-scLVM: scalable and versatile factor analysis for single-cell RNA-seq , 2017, Genome Biology.
[186] G. Ecker,et al. Predicting Ligand Interactions with ABC Transporters in ADME , 2009, Chemistry & biodiversity.
[187] Alexey I. Nesvizhskii,et al. Reconstructing targetable pathways in lung cancer by integrating diverse omics data , 2013, Nature Communications.
[188] Y. Assaraf,et al. The multi-factorial nature of clinical multidrug resistance in cancer. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[189] S. Horvath,et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006, Proceedings of the National Academy of Sciences.
[190] E. Krieger,et al. Functional Role of Arginine 375 in Transmembrane Helix 6 of Multidrug Resistance Protein 4 (MRP4/ABCC4) , 2008, Molecular Pharmacology.